US Retail Clinics Market size worth USD 4.22 Billion by 2029, at a CAGR of 10.9%

The US retail clinics market size is expected to grow from USD 3.49 Billion in 2021 to USD 4.22 Billion by 2029, at a CAGR of 10.9%. The growth is due to the increasing demand for preventive services, such as cardiovascular and cancer screenings, along with the growing awareness about the benefits of retail clinics. The increasing popularity of retail clinics has also led to the opening of new clinics, which in turn is fuelling the market growth.

The retail clinic market is divided into two segments, primary care, and specialty care. The primary care segment is expected to dominate the market.

Request Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-retail-clinics-market-106419

Strong Demand for COVID-19 Testing Expedited Investments:

The pervasive COVID-19 pandemic triggered the need for COVID-19 testing across the U.S. Stakeholders witnessed a rise in the number of patient visits to these clinics for basic healthcare services with low costs, quality, and convenience. The pandemic also compelled leading companies, including Walmart, Walgreens, and CVS to bolster their presence across the region. Concerted efforts to minimize patient visits propelled the demand for retail clinics.

Key Industry Development:

March 2021 - Geisinger announced the opening of a new clinical space at the Susquehanna Valley Mall.

Major Players Profiled in the US retail clinic market Report:

• Walmart Inc. (U.S.)
• CVS Health (U.S.)
• Walgreens Boots Alliance, Inc. (U.S.)
• Kroger | The Kroger Co (U.S.)
• Kaiser Foundation Health Plan, Inc. (U.S.)
• Target Brands, Inc. (U.S.)
• Bellin Health Systems (U.S.)
• Geisinger Health (U.S.)